Tarsus Pharmaceuticals Ownership 2024 | Who Owns Tarsus Pharmaceuticals Now?
Institutional Ownership
113.51%
Insider Ownership
8.77%
Retail Ownership
-22.28%
Institutional Holders
153.00
Tarsus Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.67% | 1.44% | 3,412,486 | 140,145 | 4.28% | 92,751,369 | Jun 30, 2024 |
| BLACKROCK INC. | 9.25% | 0.00% | 3,266,714 | 614,034 | 23.15% | 88,789,285 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 6.90% | 2.53% | 2,435,416 | -427,990 | -14.95% | 66,194,607 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 6.39% | 6.24% | 2,254,797 | - | - | 61,285,382 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 6.22% | 1.64% | 2,197,385 | 74,855 | 3.53% | 59,724,924 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.64% | 0.00% | 1,989,693 | 163,061 | 8.93% | 54,079,856 | Jun 30, 2024 |
| MORGAN STANLEY | 5.34% | 0.00% | 1,884,685 | -514,233 | -21.44% | 51,225,738 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.50% | 2.02% | 1,587,527 | -200,000 | -11.19% | 43,148,984 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 4.19% | 0.03% | 1,479,868 | 148,930 | 11.19% | 40,222,811 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 3.67% | 0.84% | 1,296,416 | - | - | 35,236,587 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 3.01% | 0.06% | 1,063,422 | 1,063,422 | 100.00% | 28,903,810 | Jun 30, 2024 |
| STATE STREET CORP | 2.62% | 0.00% | 925,639 | 208,549 | 29.08% | 25,158,868,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 2.27% | 3.79% | 800,277 | 90,000 | 12.67% | 21,751,529 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.00% | 773,235 | 143,543 | 22.80% | 21,020,137 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.90% | 0.12% | 670,459 | 454,501 | 210.46% | 18,223,000 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.78% | 0.03% | 627,578 | 148 | 0.02% | 17,057,570 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.68% | 0.03% | 594,325 | -133,566 | -18.35% | 16,153,754 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.67% | 1.52% | 590,000 | - | - | 16,036,200 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.60% | 1.42% | 565,550 | - | - | 15,371,649 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.58% | 1.58% | 556,317 | -237,512 | -29.92% | 15,120,696 | Jun 30, 2024 |
Tarsus Pharmaceuticals's largest institutional shareholder is RTW INVESTMENTS, LP, holding 9.67% of the company's total share outstanding, currently valued at $92.75M. The top 10 institutional shareholders own together 61.77% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6.39% | 6.24% | 2,254,797 | - | - | 61,285,382 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 2.27% | 3.79% | 800,277 | 90,000 | 12.67% | 21,751,529 | Jun 30, 2024 |
| TFG ASSET MANAGEMENT GP LTD | 1.42% | 3.39% | 500,000 | 50,000 | 11.11% | 13,590,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 6.90% | 2.53% | 2,435,416 | -427,990 | -14.95% | 66,194,607 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.50% | 2.02% | 1,587,527 | -200,000 | -11.19% | 43,148,984 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.67% | 2.00% | 235,000 | -65,000 | -21.67% | 6,387,300 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 6.22% | 1.64% | 2,197,385 | 74,855 | 3.53% | 59,724,924 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.58% | 1.58% | 556,317 | -237,512 | -29.92% | 15,120,696 | Jun 30, 2024 |
| SANDS CAPITAL VENTURES, LLC | 0.48% | 1.55% | 170,000 | - | - | 4,620,600 | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 0.61% | 1.53% | 216,047 | -393,057 | -64.53% | 5,872,157 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.67% | 1.52% | 590,000 | - | - | 16,036,200 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.67% | 1.44% | 3,412,486 | 140,145 | 4.28% | 92,751,369 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 1.60% | 1.42% | 565,550 | - | - | 15,371,649 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.13% | 1.03% | 400,000 | 400,000 | 100.00% | 10,872,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 3.67% | 0.84% | 1,296,416 | - | - | 35,236,587 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.42% | 0.79% | 500,000 | -1,639,102 | -76.63% | 13,590,000 | Jun 30, 2024 |
| GRANT/GROSSMENDELSOHN, LLC | 0.15% | 0.67% | 53,600 | -10 | -0.02% | 1,456,848 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.10% | 0.30% | 387,161 | 223,814 | 137.02% | 10,523,036 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.08% | 0.29% | 29,524 | -53 | -0.18% | 802,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.11% | 0.26% | 40,000 | 40,000 | 100.00% | 1,087,200 | Jun 30, 2024 |
The largest Tarsus Pharmaceuticals shareholder by % of total assets is TANG CAPITAL MANAGEMENT LLC. The company owns 2.25M shares of Tarsus Pharmaceuticals (TARS), representing 6.24% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 3.01% | 0.06% | 1,063,422 | 1,063,422 | 100.00% | 28,903,810 | Jun 30, 2024 |
| BLACKROCK INC. | 9.25% | 0.00% | 3,266,714 | 614,034 | 23.15% | 88,789,285 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.90% | 0.12% | 670,459 | 454,501 | 210.46% | 18,223,000 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.13% | 1.03% | 400,000 | 400,000 | 100.00% | 10,872,000 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 1.31% | 0.04% | 463,240 | 381,014 | 463.37% | 12,591,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.99% | 0.00% | 348,586 | 322,942 | 1259.33% | 9,474,567 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 1.29% | 0.01% | 454,991 | 304,991 | 203.33% | 12,367,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.23% | 0.03% | 434,342 | 286,516 | 193.82% | 11,805,416 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.09% | 0.00% | 385,085 | 228,298 | 145.61% | 10,466,609 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.10% | 0.30% | 387,161 | 223,814 | 137.02% | 10,523,036 | Jun 30, 2024 |
| STATE STREET CORP | 2.62% | 0.00% | 925,639 | 208,549 | 29.08% | 25,158,868,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.03% | 0.10% | 364,463 | 203,300 | 126.15% | 9,906,104 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.64% | 0.01% | 226,879 | 193,516 | 580.03% | 6,166,571 | Jun 30, 2024 |
| INVESCO LTD. | 1.11% | 0.00% | 391,563 | 167,994 | 75.14% | 10,642,683 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.64% | 0.00% | 1,989,693 | 163,061 | 8.93% | 54,079,856 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.45% | 0.07% | 160,000 | 160,000 | 100.00% | 4,348,800 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 1.19% | 0.12% | 420,758 | 150,000 | 55.40% | 11,436,202 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 4.19% | 0.03% | 1,479,868 | 148,930 | 11.19% | 40,222,811 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.00% | 773,235 | 143,543 | 22.80% | 21,020,137 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.67% | 1.44% | 3,412,486 | 140,145 | 4.28% | 92,751,369 | Jun 30, 2024 |
As of Jun 30 2024, Tarsus Pharmaceuticals's largest institutional buyer is ASSENAGON ASSET MANAGEMENT S.A.. The company purchased 1.06M stocks of TARS, valued at $28.90M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 1.42% | 0.79% | 500,000 | -1,639,102 | -76.63% | 13,590,000 | Jun 30, 2024 |
| MORGAN STANLEY | 5.34% | 0.00% | 1,884,685 | -514,233 | -21.44% | 51,225,738 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.10% | 0.03% | 389,600 | -508,400 | -56.61% | 10,589,328 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 6.90% | 2.53% | 2,435,416 | -427,990 | -14.95% | 66,194,607 | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 0.61% | 1.53% | 216,047 | -393,057 | -64.53% | 5,872,157 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 1.58% | 1.58% | 556,317 | -237,512 | -29.92% | 15,120,696 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.50% | 2.02% | 1,587,527 | -200,000 | -11.19% | 43,148,984 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.21% | 0.00% | 75,588 | -196,910 | -72.26% | 2,054,482 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -150,321 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.68% | 0.03% | 594,325 | -133,566 | -18.35% | 16,153,754 | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -100,658 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -66,300 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.67% | 2.00% | 235,000 | -65,000 | -21.67% | 6,387,300 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.83% | 0.00% | 291,275 | -56,408 | -16.22% | 7,918,000 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Tarsus Pharmaceuticals's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -1.64M shares of TARS, valued at $13.59M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 3.01% | 0.06% | 1,063,422 | 1,063,422 | 100.00% | 28,903,810 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.13% | 1.03% | 400,000 | 400,000 | 100.00% | 10,872,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.45% | 0.07% | 160,000 | 160,000 | 100.00% | 4,348,800 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.24% | 0.01% | 85,000 | 85,000 | 100.00% | 2,310,300 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.23% | 0.00% | 79,515 | 79,515 | 100.00% | 2,161,218 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.15% | 0.03% | 54,152 | 54,152 | 100.00% | 1,471,851 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.11% | 0.26% | 40,000 | 40,000 | 100.00% | 1,087,200 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.11% | 0.02% | 38,301 | 38,301 | 100.00% | 1,041,021 | Jun 30, 2024 |
| ADVISORY SERVICES NETWORK, LLC | 0.11% | 0.02% | 37,811 | 37,811 | 100.00% | 1,027,703 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.08% | 0.00% | 27,827 | 27,827 | 100.00% | 756,338 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 19,790 | 19,790 | 100.00% | 537,892 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 14,643 | 14,643 | 100.00% | 397,997 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.04% | 0.07% | 13,761 | 13,761 | 100.00% | 374,024 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.03% | 0.04% | 12,295 | 12,295 | 100.00% | 334,000 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.03% | 0.01% | 11,347 | 11,347 | 100.00% | 308,411 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.03% | 0.00% | 11,131 | 11,131 | 100.00% | 302,541 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.03% | 0.06% | 10,619 | 10,619 | 100.00% | 288,624 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.03% | 0.00% | 10,034 | 10,034 | 100.00% | 272,724 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.03% | 0.00% | 9,067 | 9,067 | 100.00% | 240,729 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.02% | 0.00% | 7,481 | 7,481 | 100.00% | 203,334 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 7,450 | 7,450 | 100.00% | 202,491 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.02% | 0.04% | 7,429 | 7,429 | 100.00% | 201,920 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.01% | 0.00% | 4,200 | 4,200 | 100.00% | 114,156 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 2,255 | 2,255 | 100.00% | 61,291 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 682 | 682 | 100.00% | 18,537 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 41 | 41 | 100.00% | 1,114 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 37 | 37 | 100.00% | 1,000 | Jun 30, 2024 |
Tarsus Pharmaceuticals's largest new institutional shareholder by number of shares is ASSENAGON ASSET MANAGEMENT S.A., purchased 1.06M shares, valued at $28.90M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -150,321 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -100,658 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -66,300 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -37,853 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -33,867 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -29,470 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -24,000 | -100.00% | - | Jun 30, 2024 |
| THOROUGHBRED FINANCIAL SERVICES, LLC | - | - | - | -20,964 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -18,696 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -16,166 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -15,200 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -14,352 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -10,537 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -7,631 | -100.00% | - | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | - | - | - | -6,147 | -100.00% | - | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | - | - | - | -6,133 | -100.00% | - | Jun 30, 2024 |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | - | - | - | -6,000 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -5,914 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -5,900 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -5,738 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -1,900 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,657 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,302 | -100.00% | - | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -79 | -100.00% | - | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -59 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Tarsus Pharmaceuticals's largest sold out institutional shareholder by shares sold is NANTAHALA CAPITAL MANAGEMENT, LLC, sold -0.15M shares, valued at -, as of undefined.
Tarsus Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.15% | 72,032 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.13% | 150,000 | - | - | Mar 28, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.12% | 248,855 | 248,855 | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.10% | 62,800 | 4,000 | 6.80% | Mar 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.08% | 354,289 | 354,289 | - | Mar 28, 2024 |
| BlackRock Health Sciences Trust II | 0.04% | 104,227 | 104,227 | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,360 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 17,061 | 11,053 | 183.97% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 51,042 | 7,436 | 17.05% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,356 | - | - | Mar 31, 2024 |
| AMG FUNDS | 0.00% | 134,950 | - | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,513,129 | -227,126 | -13.05% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 25,511 | -2,256 | -8.12% | Jan 31, 2024 |
| Humankind Benefit Corp | 0.00% | 59 | - | - | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 20,578 | 20,578 | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 81,071 | 17,555 | 27.64% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 23,605 | 564 | 2.45% | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 54,139 | 3,039 | 5.95% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 2,829 | 2,829 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 256,518 | 10,655 | 4.33% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,970 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 61,566 | -3,434 | -5.28% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 197 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,882 | 1,828 | 9.12% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 11,683 | -180 | -1.52% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 1,854 | - | - | Feb 29, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 71,191 | 10,354 | 17.02% | Jan 31, 2024 |
| ProFunds | 0.00% | 5,493 | 147 | 2.75% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 31,636 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,417 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 354,886 | 115,401 | 48.19% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,289 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,207 | 5,525 | 328.48% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,554 | -1,888 | -16.50% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 72,043 | -5,498 | -7.09% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,319 | 37 | 2.89% | Mar 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 392,843 | 146,874 | 59.71% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 141,562 | 8,354 | 6.27% | Feb 29, 2024 |
| Global X Funds | 0.00% | 10,399 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 94,104 | 29,960 | 46.71% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 10,943 | 10,509 | 2421.43% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,200 | -800 | -7.27% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 356 | -419 | -54.06% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,559 | 124 | 8.64% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 11,528 | 9,726 | 539.73% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 11,043 | 656 | 6.32% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 12,503 | -138 | -1.09% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,356,557 | 51,597 | 3.95% | Mar 31, 2024 |
| BAIRD FUNDS INC | 0.00% | 77,748 | 77,748 | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 79,013 | 8,909 | 12.71% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 126,027 | 33,507 | 36.22% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,509 | 4,982 | 945.35% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 57,168 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 5,194 | 5,194 | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 215 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 16,036 | 16,036 | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 11,012 | 1,927 | 21.21% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,000 | 300 | 42.86% | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 105,368 | 24,170 | 29.77% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 5,075 | 2,057 | 68.16% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,453 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,677 | 1,555 | 30.36% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 107 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,769 | 124 | 4.69% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 4,143 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 1,113 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 2,018 | 2,018 | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 1,629 | 1,629 | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,953 | 373 | 14.46% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 14 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,170 | 343 | 41.48% | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,885 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 21,862 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,251 | 569 | 21.22% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 50 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 16,011 | 4,711 | 41.69% | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 13,821 | 6,323 | 84.33% | Mar 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 2,527 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 21,605 | -371 | -1.69% | Mar 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 56,654 | 56,654 | - | Jan 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 15,875 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 400 | 100 | 33.33% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 11,437 | -364 | -3.08% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 867 | 303 | 53.72% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 106,922 | -5,550 | -4.93% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 11,910 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 42 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 5,852 | 5,852 | - | Mar 28, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,733 | 14,133 | 543.58% | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,582 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 5,229 | 2,221 | 73.84% | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 626 | - | - | Dec 31, 2023 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,517 | -16 | -0.45% | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 33 | - | - | Jan 31, 2024 |
Tarsus Pharmaceuticals's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 72.03K shares, compromising 0.15% of its total assets.
Tarsus Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 153 | -6.71% |
| 31 Mar, 24 | 164 | 35.54% |
| 31 Dec, 23 | 121 | 11.01% |
| 30 Sep, 23 | 109 | 14.74% |
| 30 Jun, 23 | 95 | 25.00% |
| 31 Mar, 23 | 76 | 5.56% |
| 31 Dec, 22 | 72 | -4.00% |
| 30 Sep, 22 | 75 | 2.74% |
| 30 Jun, 22 | 73 | 43.14% |
| 31 Mar, 22 | 51 | 18.60% |
| 31 Dec, 21 | 43 | -2.27% |
| 30 Sep, 21 | 44 | - |
| 30 Jun, 21 | 44 | 7.32% |
| 31 Mar, 21 | 41 | 2.50% |
| 31 Dec, 20 | 40 | - |
As of 30 Jun 24, 153 institutions are holding Tarsus Pharmaceuticals's shares, representing a decrease of -6.71% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 40,069,329 | 2.31% |
| 31 Mar, 24 | 39,163,544 | 21.70% |
| 31 Dec, 23 | 32,180,491 | 8.01% |
| 30 Sep, 23 | 29,793,106 | 38.99% |
| 30 Jun, 23 | 21,435,682 | 6.87% |
| 31 Mar, 23 | 20,057,975 | -2.75% |
| 31 Dec, 22 | 20,624,782 | 0.66% |
| 30 Sep, 22 | 20,489,141 | 2.54% |
| 30 Jun, 22 | 19,981,073 | 51.25% |
| 31 Mar, 22 | 13,210,424 | 1.05% |
| 31 Dec, 21 | 13,073,070 | 1.58% |
| 30 Sep, 21 | 12,869,550 | -1.47% |
| 30 Jun, 21 | 13,061,736 | 2.35% |
| 31 Mar, 21 | 12,761,893 | 0.02% |
| 31 Dec, 20 | 12,759,603 | - |
Tarsus Pharmaceuticals (TARS) has 40.07M shares outstanding as of 30 Jun 24, up 2.31% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.51% | 0.92% |
| 31 Mar, 24 | 110.94% | 0.92% |
| 31 Dec, 23 | 109.52% | 1.16% |
| 30 Sep, 23 | 97.29% | 1.52% |
| 30 Jun, 23 | 79.94% | 1.42% |
| 31 Mar, 23 | 75.01% | 1.26% |
| 31 Dec, 22 | 77.17% | 1.31% |
| 30 Sep, 22 | 76.85% | 1.10% |
| 30 Jun, 22 | 83.50% | 2.04% |
| 31 Mar, 22 | 63.97% | 1.58% |
| 31 Dec, 21 | 63.60% | 1.64% |
| 30 Sep, 21 | 62.35% | 1.54% |
| 30 Jun, 21 | 63.54% | 1.61% |
| 31 Mar, 21 | 62.76% | 1.59% |
| 31 Dec, 20 | 62.74% | - |
As of 30 Jun 24, Tarsus Pharmaceuticals is held by 113.51% institutional shareholders, representing a 0.92% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 94 | -9.62% |
| 31 Mar, 24 | 104 | 38.67% |
| 31 Dec, 23 | 75 | - |
| 30 Sep, 23 | 75 | 19.05% |
| 30 Jun, 23 | 63 | 70.27% |
| 31 Mar, 23 | 37 | - |
| 31 Dec, 22 | 37 | 5.71% |
| 30 Sep, 22 | 35 | -35.19% |
| 30 Jun, 22 | 54 | 170.00% |
| 31 Mar, 22 | 20 | 5.26% |
| 31 Dec, 21 | 19 | 18.75% |
| 30 Sep, 21 | 16 | -40.74% |
| 30 Jun, 21 | 27 | 58.82% |
| 31 Mar, 21 | 17 | -57.50% |
| 31 Dec, 20 | 40 | - |
94 institutional shareholders have increased their position in TARS stock as of 30 Jun 24 compared to 104 in the previous quarter (a -9.62% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 43 | 34.38% |
| 31 Mar, 24 | 32 | 28.00% |
| 31 Dec, 23 | 25 | 92.31% |
| 30 Sep, 23 | 13 | -7.14% |
| 30 Jun, 23 | 14 | -30.00% |
| 31 Mar, 23 | 20 | 5.26% |
| 31 Dec, 22 | 19 | -9.52% |
| 30 Sep, 22 | 21 | 162.50% |
| 30 Jun, 22 | 8 | -57.89% |
| 31 Mar, 22 | 19 | 137.50% |
| 31 Dec, 21 | 8 | -50.00% |
| 30 Sep, 21 | 16 | 77.78% |
| 30 Jun, 21 | 9 | -25.00% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | - | - |
43 institutional shareholders have reduced their position in TARS stock as of 30 Jun 24 compared to 32 in the previous quarter (a 34.38% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 153 | -6.71% | 40,069,329 | 2.31% | 113.51% | 0.92% | 94 | -9.62% | 43 | 34.38% |
| 31 Mar, 24 | 164 | 35.54% | 39,163,544 | 21.70% | 110.94% | 0.92% | 104 | 38.67% | 32 | 28.00% |
| 31 Dec, 23 | 121 | 11.01% | 32,180,491 | 8.01% | 109.52% | 1.16% | 75 | - | 25 | 92.31% |
| 30 Sep, 23 | 109 | 14.74% | 29,793,106 | 38.99% | 97.29% | 1.52% | 75 | 19.05% | 13 | -7.14% |
| 30 Jun, 23 | 95 | 25.00% | 21,435,682 | 6.87% | 79.94% | 1.42% | 63 | 70.27% | 14 | -30.00% |
| 31 Mar, 23 | 76 | 5.56% | 20,057,975 | -2.75% | 75.01% | 1.26% | 37 | - | 20 | 5.26% |
| 31 Dec, 22 | 72 | -4.00% | 20,624,782 | 0.66% | 77.17% | 1.31% | 37 | 5.71% | 19 | -9.52% |
| 30 Sep, 22 | 75 | 2.74% | 20,489,141 | 2.54% | 76.85% | 1.10% | 35 | -35.19% | 21 | 162.50% |
| 30 Jun, 22 | 73 | 43.14% | 19,981,073 | 51.25% | 83.50% | 2.04% | 54 | 170.00% | 8 | -57.89% |
| 31 Mar, 22 | 51 | 18.60% | 13,210,424 | 1.05% | 63.97% | 1.58% | 20 | 5.26% | 19 | 137.50% |
| 31 Dec, 21 | 43 | -2.27% | 13,073,070 | 1.58% | 63.60% | 1.64% | 19 | 18.75% | 8 | -50.00% |
| 30 Sep, 21 | 44 | - | 12,869,550 | -1.47% | 62.35% | 1.54% | 16 | -40.74% | 16 | 77.78% |
| 30 Jun, 21 | 44 | 7.32% | 13,061,736 | 2.35% | 63.54% | 1.61% | 27 | 58.82% | 9 | -25.00% |
| 31 Mar, 21 | 41 | 2.50% | 12,761,893 | 0.02% | 62.76% | 1.59% | 17 | -57.50% | 12 | - |
| 31 Dec, 20 | 40 | - | 12,759,603 | - | 62.74% | - | 40 | - | - | - |
Tarsus Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tarsus Pharmaceuticals's stock was made by LINK WILLIAM J PHD on Aug 14 2024, selling 74,892 shares at - per share (valued at -).
Tarsus Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 3 | 66.67% |
| Q2 2024 | 22 | 9 | 244.44% |
| Q1 2024 | 18 | 15 | 120.00% |
| Q4 2023 | 4 | 14 | 28.57% |
| Q3 2023 | 2 | 7 | 28.57% |
| Q2 2023 | 23 | 21 | 109.52% |
| Q1 2023 | 23 | 69 | 33.33% |
| Q4 2022 | 6 | 24 | 25.00% |
| Q3 2022 | 4 | 8 | 50.00% |
| Q2 2022 | 18 | 7 | 257.14% |
| Q1 2022 | 17 | - | - |
| Q4 2021 | 2 | 27 | 7.41% |
| Q3 2021 | 3 | 18 | 16.67% |
| Q2 2021 | 9 | 7 | 128.57% |
| Q1 2021 | 7 | 1 | 700.00% |
| Q4 2020 | 26 | 45 | 57.78% |
2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by Tarsus Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | 1 | 11 | 9.09% |
| Q3 2023 | 1 | 6 | 16.67% |
| Q2 2023 | - | 13 | - |
| Q1 2023 | - | 60 | - |
| Q4 2022 | - | 21 | - |
| Q3 2022 | 2 | 7 | 28.57% |
| Q2 2022 | 1 | 6 | 16.67% |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 23 | - |
| Q3 2021 | - | 16 | - |
| Q2 2021 | - | 7 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 6 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Tarsus Pharmaceuticals's stocks.
Tarsus Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| NUVL | Nuvalent, Inc. |
| NUVB | Nuvation Bio Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| IKNA | Ikena Oncology, Inc. |
| ALDX | Aldeyra Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| LIAN | LianBio |
| ETON | Eton Pharmaceuticals, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| RLYB | Rallybio Corporation |
| CNTB | Connect Biopharma Holdings Limited |
| TRDA | Entrada Therapeutics, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| PHVS | Pharvaris N.V. |
| HOWL | Werewolf Therapeutics, Inc. |
| PEPG | PepGen Inc. |
| GNFT | Genfit S.A. |
| OPT | Opthea Limited |
TARS Ownership FAQ
Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals is owned by institutional shareholders (113.51%), insiders (8.77%), and public (-22.28%). The largest institutional shareholder of Tarsus Pharmaceuticals is RTW INVESTMENTS, LP (9.67% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.15% of total shares).
Who are the major institutional shareholders of Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals's major institutional shareholders are RTW INVESTMENTS, LP, BLACKROCK INC., PARADIGM BIOCAPITAL ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, and COWEN AND COMPANY, LLC. The top five shareholders own together 38.43% of the company's share outstanding.
How many Tarsus Pharmaceuticals shareholders are there?
As of Jun 2024, there are 153 institutional shareholders of Tarsus Pharmaceuticals.
What percentage of Tarsus Pharmaceuticals is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP owns 3.41M shares of Tarsus Pharmaceuticals, representing 9.67% of the company's total shares outstanding, valued at $92.75M (as of Jun 2024).
What percentage of Tarsus Pharmaceuticals is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 3.27M shares of Tarsus Pharmaceuticals (TARS), compromising 9.25% of the company, valued at $88.79M.
What percentage of Tarsus Pharmaceuticals is owned by PARADIGM BIOCAPITAL ADVISORS LP?
PARADIGM BIOCAPITAL ADVISORS LP is the third largest holder of Tarsus Pharmaceuticals. The company owns 2.44M of the company's shares outstanding (worth $66.19M).